664 related articles for article (PubMed ID: 18523134)
1. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
2. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics.
Kronman C; Cohen O; Mazor O; Ordentlich A; Raveh L; Velan B; Shafferman A
Chem Biol Interact; 2010 Sep; 187(1-3):253-8. PubMed ID: 20005217
[TBL] [Abstract][Full Text] [Related]
3. Polyethylene-glycol conjugated recombinant human acetylcholinesterase serves as an efficacious bioscavenger against soman intoxication.
Kronman C; Cohen O; Raveh L; Mazor O; Ordentlich A; Shafferman A
Toxicology; 2007 Apr; 233(1-3):40-6. PubMed ID: 17045722
[TBL] [Abstract][Full Text] [Related]
4. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
5. Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning.
Saxena A; Maxwell DM; Quinn DM; Radić Z; Taylor P; Doctor BP
Biochem Pharmacol; 1997 Jul; 54(2):269-74. PubMed ID: 9271331
[TBL] [Abstract][Full Text] [Related]
6. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
7. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
[TBL] [Abstract][Full Text] [Related]
9. Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.
Kovarik Z; Maček Hrvat N; Katalinić M; Sit RK; Paradyse A; Žunec S; Musilek K; Fokin VV; Taylor P; Radić Z
Chem Res Toxicol; 2015 May; 28(5):1036-44. PubMed ID: 25835984
[TBL] [Abstract][Full Text] [Related]
10. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
12. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
[TBL] [Abstract][Full Text] [Related]
14. Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.
Ordentlich A; Barak D; Kronman C; Benschop HP; De Jong LP; Ariel N; Barak R; Segall Y; Velan B; Shafferman A
Biochemistry; 1999 Mar; 38(10):3055-66. PubMed ID: 10074358
[TBL] [Abstract][Full Text] [Related]
15. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
16. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase-Fc Fusion Protein (AChE-Fc): A Novel Potential Organophosphate Bioscavenger with Extended Plasma Half-Life.
Noy-Porat T; Cohen O; Ehrlich S; Epstein E; Alcalay R; Mazor O
Bioconjug Chem; 2015 Aug; 26(8):1753-8. PubMed ID: 26121420
[TBL] [Abstract][Full Text] [Related]
18. Phosphylation kinetic constants and oxime-induced reactivation in acetylcholinesterase from fetal bovine serum, bovine caudate nucleus, and electric eel.
Hanke DW; Overton MA
J Toxicol Environ Health; 1991 Sep; 34(1):141-56. PubMed ID: 1890690
[TBL] [Abstract][Full Text] [Related]
19. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters.
Masson P; Nachon F; Broomfield CA; Lenz DE; Verdier L; Schopfer LM; Lockridge O
Chem Biol Interact; 2008 Sep; 175(1-3):273-80. PubMed ID: 18508040
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
